Ten-Year Global Postmarket Safety Surveillance of Delayed Complications With a Flexible Cheek Filler.
作者信息
Cohen Joel L, Patel Monika, Hicks Jessica
机构信息
Department of Dermatology, University of California Irvine, Irvine, California; AboutSkin Dermatology and AboutSkin Research, Greenwood Village, Colorado.
Galderma Aesthetics, Medical Affairs, Fort Worth, Texas.
出版信息
Dermatol Surg. 2022 Oct 1;48(10):1126-1127. doi: 10.1097/DSS.0000000000003587. Epub 2022 Sep 15.
Abstract
摘要
相似文献
1
Ten-Year Global Postmarket Safety Surveillance of Delayed Complications With a Flexible Cheek Filler.
Dermatol Surg. 2022 Oct 1;48(10):1126-1127. doi: 10.1097/DSS.0000000000003587. Epub 2022 Sep 15.
2
Perspectives on the future of postmarket vaccine safety surveillance and evaluation.
Expert Rev Vaccines. 2014 Apr;13(4):455-62. doi: 10.1586/14760584.2014.891941.
3
A Comprehensive Analysis of Postmarket Surveillance Study Orders: Device Characteristics, Study Statuses, Outcomes, and Potential Contributions.
Ther Innov Regul Sci. 2020 Jul;54(4):953-963. doi: 10.1007/s43441-020-00113-7. Epub 2020 Jan 29.
4
Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States.
Clin Pharmacol Ther. 2021 Jun;109(6):1424-1442. doi: 10.1002/cpt.2010. Epub 2020 Oct 11.
5
Overview of contact lens postmarket surveillance in the United States: system and recent study results.
Eye Contact Lens. 2013 Jan;39(1):109-14. doi: 10.1097/ICL.0b013e31827c9939.
6
Postmarket surveillance and returned product analysis: success but not transparency.
Heart Rhythm. 2013 Oct;10(10):1469-70. doi: 10.1016/j.hrthm.2013.08.001. Epub 2013 Aug 3.
7
Characteristics of Novel Therapeutics and Postmarket Safety Events.
JAMA. 2017 Sep 19;318(11):1067. doi: 10.1001/jama.2017.11513.
8
SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION: A Comprehensive Analysis of Premarketing and Postmarketing Experiences.
Retina. 2015 Jun;35(6):1128-34. doi: 10.1097/IAE.0000000000000519.
9
Characteristics of Novel Therapeutics and Postmarket Safety Events-Reply.
JAMA. 2017 Sep 19;318(11):1067-1068. doi: 10.1001/jama.2017.11517.
10
[United States Medical Device Postmarket Surveillance System Operational Experience and Learning].
Zhongguo Yi Liao Qi Xie Za Zhi. 2017 Mar 30;41(2):123-126. doi: 10.3969/j.issn.1671-7104.2017.02.013.
引用本文的文献
1
Case report: Improving quality of life through hyaluronic acid-based fillers after orbital cancer treatment.
Front Oncol. 2024 Dec 18;14:1501556. doi: 10.3389/fonc.2024.1501556. eCollection 2024.
2
Good scientific practice of using worldwide post-marketing surveillance data to ensure safety with HA BDDE cross-linked hyaluronic acid fillers.
Drugs Context. 2024 Dec 18;13. doi: 10.7573/dic.2024-10-6. eCollection 2024.
Zotero 插件